Loading...
Loading...
STAA| Name | Value |
|---|---|
| Revenues | 77.4M |
| Cost of Revenue | 16.3M |
| Gross Profit | 61.0M |
| Operating Expense | 63.3M |
| Operating I/L | -2.3M |
| Other Income/Expense | 0.1M |
| Interest Income | 1.5M |
| Pretax | -2.2M |
| Income Tax Expense | 1.1M |
| Net Income/Loss | -3.3M |
STAAR Surgical Company designs, manufactures, and sells implantable lenses for the eye, including the Visian implantable Collamer lens product family (ICLs) and Hyperopic ICL, as well as preloaded silicone cataract intraocular lenses and injector systems for cataract surgery. The company also provides companion delivery systems and related instruments and devices. Its products are primarily used by ophthalmologists to treat visual disorders such as myopia, hyperopia, astigmatism, and presbyopia. STAAR Surgical Company markets its products directly through sales representatives in several countries and also utilizes independent distributors internationally.
